BFLY 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• Units fulfilled increased by 1,176 units, or 22.5%, for the three months ended June 30, 2026 compared to the three months ended June 30, 2025. The increase was largely driven by higher probe sales volume in the U.S. through direct sales to health systems and medical schools as well as our eCommerce …

• Product revenue decreased by $0.9 million, or 5.4%, for the three months ended June 30, 2026 compared to the three months ended June 30, 2025. The overall decrease was driven by the non-recurrence of prior-year sales of semiconductor

• chips to our Embedded partners, reducing current-year product revenue by $1.3 million. This decrease was partially offset by $0.4 million of higher product revenue generated from the increase in probe sales volume within our core business.

• Software and other services revenue increased by $10.1 million, or 149.8%, for the three months ended June 30, 2026 compared to the three months ended June 30, 2025. This increase was primarily driven by increases in software and other services revenue generated by our Embedded partnerships, includi…

• Cost of product revenue increased by $0.7 million, or 10.5%, for the three months ended June 30, 2026 compared to the three months ended June 30, 2025, primarily driven by the increased cost of devices sold as a result of our higher probe sales volume.

相对上期删除的文字 · 来源:10-Q · 2026-04-30

• Units fulfilled increased by 234 units, or 4.9%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The increase was driven by higher probe sales volume in our international distributor and veterinary sales channels, with veterinary sales positively impacted…

• Comparison of the three months ended March 31, 2026 and 2025

• Product revenue increased by $0.5 million, or 3.5%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This increase was driven by higher probe sales volume in our international distributor and veterinary sales channels, with veterinary sales positively impa…

• and some international markets in the fourth quarter of 2025. We also experienced a favorable shift year-over-year in our product sales mix with a higher proportion of sales of our current-generation iQ3 probes that have a higher selling price than our previous-generation iQ+ probes.

• Software and other services revenue increased by $4.8 million, or 68.2%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This increase was primarily driven by increases in software and other services revenue generated by our Embedded partnerships.

相对上期新增的文字 · 来源:10-Q · 2026-07-30

• During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement", as each term is defined in Item 408 of Regula…

相对上期删除的文字 · 来源:10-Q · 2026-04-30

• On March 13, 2026, Dr. Jonathan Rothberg, a member of our board of directors, and entities owned by trusts created for the benefit of Dr. Rothberg's children adopted a "Rule 10b5-1 trading arrangement" (as such term is defined in Item 408 of Regulation S-K), pursuant to which Dr. Rothberg has author…

• During the three months ended March 31, 2026, none of our other directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement", as each term is defined in Item 408 of…